Cardiogenic shock (CS) is a leading cause of mortality worldwide. CS presentation and management in the current era have been widely depicted in epidemiological studies. Its treatment is codified and relies on medical care and extracorporeal life support (ECLS) in the bridge to recovery, chronic mechanical device therapy, or transplantation. Recent improvements have changed the landscape of CS. The present analysis aims to review current medical treatments of CS in light of recent literature, including addressing excitation–contraction coupling and specific physiology on applied hemodynamics. Inotropism, vasopressor use, and immunomodulation are discussed as pre-clinical and clinical studies have focused on new therapeutic options to improve patient outcomes. Certain underlying conditions of CS, such as hypertrophic or Takotsubo cardiomyopathy, warrant specifically tailored management that will be overviewed in this review.
The medical treatment of cardiogenic shock
【摘 要】
:
Cardiogenicshock(CS)isaleadingcauseofmortalityworldwide.CSpresentationandmanagementinthecurrenterahavebeenwidelydepictedinepidemiologicalstudies.Itstreatmentiscodifiedandreliesonmedicalcareandextracorporeallifesupport(ECLS)inthebridgetorecovery,chronicmec
【出 处】
:
重症医学(英文)
【发表日期】
:
2023年03期
论文部分内容阅读
其他文献
Nomogram for Predicting Viral Shedding Time of SARS-CoV-2 Delta Variant in Patients with COVID-19: A
Background:Thecoronavirusdisease2019(COVID-19)casescontinuetorise,andthedemandformedicaltreatmentandresourcesinhealthcaresystemssurges.Assessingtheviralsheddingtime(VST)ofpatientswithCOVID-19canfacilitateclinicaldecisionmaking.Althoughsomestudieshavebeenc
Effect of Different Factors on the Quality of Life and Sequelae of COVID-19 Patients After Discharge
Background:Thecontinuedspreadofsevereacuterespiratorysyndromecoronavirus2(SARS-CoV-2)remainsaninternationalpublichealthemergency,resultinginasignificantglobaldiseaseburden.Thelong-termeffectsofSARS-CoV-2infectioninhumansandthelong-termprognosisofpatientsw
Thesevereacuterespiratorysyndromecoronavirus2(SARS-CoV-2)infectionhasresultedinnumerousconfirmedcasesanddeathsworldwide.RecentstudieshaveshownthatpeoplelivingwithHIV(PLWH)arepronetodevelopsevereillnessandpooroutcomesiftheyexperiencecoronavirusdisease2019(
Treatment of More Than Moderate Ischemic Mitral Regurgitation in Patients Undergoing Left Ventricula
A Randomized Controlled Trial of a Biodegradable Polymer, Microcrystalline Sirolimus-Eluting Stent (
Effects of Glucose Fluctuations on Electrocardiogram Readings and the Development of Ventricular Arr
The Efficacy and Safety of Tolvaptan in Heart Failure Patients with Congestive Signs: A Systematic R